ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive and behavioral disturbances are increasingly recognized as core features of Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA), with important clinical and prognostic implications. In PSP, cognitive impairment-often an early sign-is dominated by a dysexecutive syndrome linked to dorsolateral prefrontal atrophy and fronto-subcortical circuit disruption. Deficits also extend to attention, memory, language, visuospatial abilities, and social cognition. Apathy is the most common behavioral symptom, associated with medial prefrontal and subcortical atrophy, while impulsivity, disinhibition, and mood symptoms reflect broader orbitofrontal and posterior cortical involvement. Imaging studies highlight frontooccipital white matter disruption and subcortical tau deposition as key contributors to these features. In MSA, cognitive impairment is typically milder and more variable, most commonly involving executive dysfunction related to fronto-subcortical and cerebellar degeneration. Memory and visuospatial issues usually stem from impaired executive control. Behavioral symptoms-especially apathy and depression-are frequent but underrecognized. Frontal and cerebellar atrophy, along with disrupted striato-frontal connectivity and reduced metabolism, correlate with these changes. Autonomic dysfunction, particularly orthostatic hypotension, may further exacerbate cognitive decline through cerebral hypoperfusion. These findings underscore the importance of early detection of cognitive and behavioral symptoms in PSP and MSA. Given their significant impact on quality of life and functional decline, comprehensive assessment tools and multidisciplinary care approaches are essential to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.